China’s decision to effectively quash a deal for Canada to test and produce a Chinese-made COVID-19 vaccine cost the government more than a quarter-million dollars, newly released figures indicates.
The National Research Council (NRC) paid Dalhousie University $253,997 to conduct a clinical trial of the CanSino Biologics vaccine last year — though the trial had to be called off before any patients were actually treated, a disclosure document posted online says.
